Transjugular Intrahepatic Portosystemic Shunt for Patients With Portal Hypertension: an Observational, Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This is a single-center, prospective, observational study intended to include patients receiving TIPS for portal hypertension. Baseline data of enrolled patients were recorded, and samples of ascites, feces and urine were collected before surgery. Venous blood (superior mesenteric vein, hepatic vein, peripheral vein) from different parts of the entero-hepatic axis was retained during operation, and patients were followed up regularly for 2 years. The incidence of infection, hepatic encephalopathy, upper gastrointestinal hemorrhage and ascites in patients with portal hypertension who received TIPS intervention were observed within 3 months after operation. And the stent patency was observed within 2 years after surgery. To investigate the characteristics of microbial, protein and metabolic components on enterohepatic axis and their relationship with prognosis of patients with cirrhosis by detecting microbiome, proteome and metabolome.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Patients undergoing TIPS due to complications related to portal hypertension;

• Age between 18 to 85 years;

• Signed informed consent;

Locations
Other Locations
China
Nanfang hospital, Southern Medical Uiversity
RECRUITING
Guangzhou
Contact Information
Primary
Xiaofeng Zhang
1282614092@qq.com
+8618565552050
Time Frame
Start Date: 2021-01-01
Estimated Completion Date: 2025-01-31
Participants
Target number of participants: 300
Treatments
Patients undergoing TIPS procedure
Patients undergoing TIPS procedure due to portal hypertension-related complications
Sponsors
Leads: Nanfang Hospital, Southern Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials